Page 119 - Patent Coverage News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Patent coverage. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Patent Coverage Today - Breaking & Trending Today

Regeneron Sues Samsung Bioepis For Proposed Biosimilar Of EYLEA In West Virginia District Court - Life Sciences, Biotechnology & Nanotechnology

Regeneron Pharmaceuticals, Inc. ("Regeneron") filed a Complaint on November 22 against Samsung Bioepis Co., Ltd. ("Bioepis") in the U.S. District Court for the Northern District of West Virginia. ....

West Virginia , United States , Us District Court , Bioepis Co Ltd , Regeneron Pharmaceuticals Inc , Regeneron Pharmaceuticals , Northern District , Commercial Marketing , Big Molecule Watch , Biosimilars News , Samsung Bioepis , Life Sciences , Life Sciences , Iotechnology Amp Nanotechnology , Intellectual Property ,

Fusion Orthopedics latest to win patent infringement battle against Extremity

Fusion Orthopedics wins patent infringement case against Extremity Medical, Zimmer Biomet and Paragon 28. The USPTO s Patent Trial and Appeal Board ruled agains ....

Zimmer Biomet , Trademark Office Patent Trial , Trademark Office , Patent Trial , Appeal Board , Extremity Medical , Fusion Orthopedics , Fusion Orthopedic Intralock , Patent Trial And Appeal Board , Fusion Orthopedics , Zimmer Biomet , Paragon 28 , Ntralock Device , Atent 166 ,

How Is Patent Term Extension Calculated For A Reissued Patent? - Patent

The Patent Term Extension (PTE) provisions of 35 U.S.C. 256 were enacted as part of the Drug Price Competition and Patent Term Restoration Act of 1984. ....

Drug Administration , Patent Term Extension , Drug Price Competition , Patent Term , Restoration Act , Reissued Patent , Federal Circuit , How Is Patent Term Extension Calculated Fora Reissued , Intellectual Property ,

The Duty Of Disclosure | What It Is | How And When To Satisfy It - Patent

Under U.S. law (i.e., 37 CFR § 1.56) each and every individual associated with the filing and prosecution of a patent application has a duty of candor and good faith in dealing with the United States Patent and Trademark Office. ....

United States , Trademark Office , United States Patent , Information Disclosure , The Duty Of Disclosure What It Is How And When To Satisfy , Intellectual Property ,

The Uncertainty Of Obviousness: Some Strategies Moving Forward - Patent

When the Supreme Court eliminated the "teaching-suggestion-motivation" test in KSR International Co. v. Teleflex Inc., it also eliminated the certainty regarding what is obvious and what is not obvious. ....

Nuvasive Inc , Apple Inc , Personalweb Technologies , International Co , Supreme Court , Teleflex Inc , Appeals Board , Procedure Act , The Uncertainty Of Obviousness Some Strategies Moving Forward , Intellectual Property ,